CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 38 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $4,790,000 | +11.1% | 1,501,716 | 0.0% | 1.30% | +20.3% |
| Q4 2021 | $4,310,000 | -27.7% | 1,501,716 | 0.0% | 1.08% | -16.8% |
| Q3 2021 | $5,962,000 | -33.4% | 1,501,716 | 0.0% | 1.30% | -19.1% |
| Q2 2021 | $8,950,000 | -50.9% | 1,501,716 | 0.0% | 1.60% | -84.9% |
| Q1 2021 | $18,231,000 | -16.8% | 1,501,716 | 0.0% | 10.62% | -16.6% |
| Q4 2020 | $21,910,000 | +26.8% | 1,501,716 | 0.0% | 12.73% | +54.3% |
| Q3 2020 | $17,284,000 | – | 1,501,716 | – | 8.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|